Literature DB >> 25767288

Clinical value of ambulatory blood pressure: evidence and limits.

Giuseppe Mancia1, Paolo Verdecchia2.   

Abstract

This article reviews the clinical value of ambulatory blood pressure (BP) vis-à-vis the traditional BP measurements taken in the physician's office or in the hospital. Mention is initially made that longitudinal studies conducted in the general population or in hypertensive cohorts have shown that ambulatory BP provides a more accurate prediction of outcome than office BP. Namely, that (1) the risk of cardiovascular events increases in a less steep fashion with office than with 24-hour mean BP, (2) the 24-hour BP-dependent prediction is maintained after adjustment for office BP values, and (3) among individuals with normal office BP, those with increased ambulatory BP (masked hypertension) have an increased prevalence of organ damage, a more frequent unfavorable metabolic profile and a higher risk of new onset sustained hypertension, diabetes mellitus, and cardiovascular events than those with normal ambulatory BP. It is further mentioned, however, that more recently similar observations have been made for individuals with high office but normal ambulatory BP (white coat hypertension) suggesting a complementary role of out-of-office and office BP values in the determination of patients' prognosis. The evidence in favor of an independent prognostic value also of some within 24-hour BP phenomena (night BP reduction or absolute values, short-term BP variations, and morning BP surge) is then critically appraised for its elements of strength and weakness. Finally, whether the clinical advantages of ambulatory BP make this approach necessary for all patients with hypertension is discussed. The conclusion is that this is at present still premature because crucial evidence pro or against routine use of this approach in untreated and treated hypertensives is not yet available. It will be crucial for future studies to determine whether, compared with a treatment guided by office BP, a treatment tailored on ambulatory BP allows to improve prevention or regression of organ damage as well as protection from major cardiovascular complications to a degree that justifies the complexity and cost of the procedure.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; cardiovascular diseases; end-stage renal disease; hypertension; masked hypertension; white coat hypertension

Mesh:

Year:  2015        PMID: 25767288     DOI: 10.1161/CIRCRESAHA.116.303755

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  49 in total

Review 1.  Hypertension: history and development of established and novel treatments.

Authors:  Milan Wolf; Sebastian Ewen; Felix Mahfoud; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2018-06-27       Impact factor: 5.460

2.  Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes.

Authors:  Raija Lithovius; Daniel Gordin; Carol Forsblom; Markku Saraheimo; Valma Harjutsalo; Per-Henrik Groop
Journal:  Diabetologia       Date:  2018-05-24       Impact factor: 10.122

Review 3.  Big Data and Blood Pressure Control: Insights from the PAMELA and BP-CARE Study Cohorts.

Authors:  M Bombelli; Rita Facchetti; Giuseppe Mancia; Guido Grassi
Journal:  Curr Hypertens Rep       Date:  2018-07-26       Impact factor: 5.369

4.  Isolated nocturnal hypertension: an unsolved problem-when to start treatment and how low should we go?

Authors:  Milovan Stojanovic; Marina Deljanin-Ilic; Stevan Ilic; Bojan Ilic
Journal:  J Hum Hypertens       Date:  2020-08-19       Impact factor: 3.012

Review 5.  Ambulatory Blood Pressure Monitoring: A Complementary Strategy for Hypertension Diagnosis and Management in Low-Income and Middle-Income Countries.

Authors:  Marwah Abdalla
Journal:  Cardiol Clin       Date:  2017-02       Impact factor: 2.213

6.  Association of nocturnal blood pressure patterns with inflammation and central and peripheral estimates of vascular health in rheumatoid arthritis.

Authors:  Eugenia Gkaliagkousi; Panagiota Anyfanti; Sophia Chatzimichailidou; Areti Triantafyllou; Antonios Lazaridis; Spyros Aslanidis; Stella Douma
Journal:  J Hum Hypertens       Date:  2018-03-09       Impact factor: 3.012

Review 7.  The Utility of Ambulatory Blood Pressure Monitoring for Diagnosing White Coat Hypertension in Older Adults.

Authors:  Kristi Reynolds; C Barrett Bowling; John J Sim; Lakshmi Sridharan; Teresa N Harrison; Daichi Shimbo
Journal:  Curr Hypertens Rep       Date:  2015-11       Impact factor: 5.369

Review 8.  Prognostic Importance of Ambulatory Blood Pressure Monitoring in Resistant Hypertension: Is It All that Matters?

Authors:  Claudia R L Cardoso; Gil F Salles
Journal:  Curr Hypertens Rep       Date:  2016-12       Impact factor: 5.369

9.  Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients.

Authors:  Raffaella Dell'Oro; Alessandro Maloberti; Francesco Nicoli; Paolo Villa; Pierluigi Gamba; Michele Bombelli; Giuseppe Mancia; Guido Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-06-12

10.  New Recommendations for the Treatment of Systemic Hypertension and their Potential Implications for Glaucoma Management.

Authors:  Carlos G De Moraes; George A Cioffi; Robert N Weinreb; Jeffrey M Liebmann
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.